{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T17:46:16Z","timestamp":1788716776691,"version":"build-2803163510"},"reference-count":26,"publisher":"Elsevier BV","issue":"34","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.vaccine.2018.07.011","type":"journal-article","created":{"date-parts":[[2018,7,19]],"date-time":"2018-07-19T21:04:13Z","timestamp":1532034253000},"page":"5173-5179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Pertussis Immunisation in Pregnancy Safety (PIPS) Study: A retrospective cohort study of safety outcomes in pregnant women vaccinated with Tdap vaccine"],"prefix":"10.1016","volume":"36","author":[{"given":"Jennifer B.","family":"Griffin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennex","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikki","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Walls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna S.","family":"Howe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Petousis-Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2018.07.011_b0005","doi-asserted-by":"crossref","first-page":"334.e1","DOI":"10.1016\/j.ajog.2010.11.024","article-title":"Maternal immunization with tetanus\u2013diphtheria\u2013pertussis vaccine: effect on maternal and neonatal serum antibody levels","volume":"204","author":"Gall","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2018.07.011_b0010","unstructured":"Centers for Disease Control and Prevention (CDC). Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months---Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morbidity and mortality weekly report. 2011;60(41):1424."},{"key":"10.1016\/j.vaccine.2018.07.011_b0015","unstructured":"Joint Committee on Vaccination and Immunisation (JCVI). Minute of the meeting 2012 [22\/12\/2017]. Available from: http:\/\/webarchive.nationalarchives.gov.uk\/20130402213846\/http:\/\/transparency.dh.gov.uk\/2012\/10\/03\/jcvi-meeting-october-2012\/."},{"key":"10.1016\/j.vaccine.2018.07.011_b0020","unstructured":"Advisory Committee on Immunization Practices (ACIP). Summary Report February 23-24, 2011 [Internet]. Atlanta, Georgia2011. Available from: http:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/min-archive\/min-feb11.pdf."},{"issue":"5","key":"10.1016\/j.vaccine.2018.07.011_b0025","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.jpeds.2013.06.021","article-title":"Diphtheria, acellular pertussis vaccine during pregnancy: pregnancy and infant health outcomes","volume":"163","author":"Shakib","year":"2013","journal-title":"J Pediatrics"},{"key":"10.1016\/j.vaccine.2018.07.011_b0030","first-page":"e1","article-title":"Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women","volume":"59","author":"Zheteyeva","year":"20122071","journal-title":"Am J Obstet Gynecol"},{"issue":"50","key":"10.1016\/j.vaccine.2018.07.011_b0035","doi-asserted-by":"crossref","first-page":"8001","DOI":"10.1016\/j.vaccine.2010.09.034","article-title":"The safety of immunizing with tetanus\u2013diphtheria\u2013acellular pertussis vaccine (Tdap) less than 2 years following previous tetanus vaccination: Experience during a mass vaccination campaign of healthcare personnel during a respiratory illness outbreak","volume":"28","author":"Talbot","year":"2010","journal-title":"Vaccine"},{"issue":"17","key":"10.1016\/j.vaccine.2018.07.011_b0040","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1001\/jama.2014.3633","article-title":"Safety and immunogenicity of tetanus diphtheria and acellular pertussis (tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial","volume":"311","author":"Munoz","year":"2014","journal-title":"JAMA: J Am Med Assoc"},{"issue":"9953","key":"10.1016\/j.vaccine.2018.07.011_b0045","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/S0140-6736(14)60686-3","article-title":"Effectiveness of maternal pertussis vaccination in England: an observational study","volume":"384","author":"Amirthalingam","year":"2014","journal-title":"The Lancet"},{"issue":"18","key":"10.1016\/j.vaccine.2018.07.011_b0050","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1001\/jama.2014.14825","article-title":"Evaluation of the association of maternal pertussis vaccination with obstetric events and birth outcomes","volume":"312","author":"Kharbanda","year":"2014","journal-title":"Jama"},{"issue":"5","key":"10.1016\/j.vaccine.2018.07.011_b0055","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1097\/AOG.0000000000001066","article-title":"Safety of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis and influenza vaccinations in pregnancy","volume":"126","author":"Sukumaran","year":"2015","journal-title":"Obstetrics Gynecol"},{"issue":"20","key":"10.1016\/j.vaccine.2018.07.011_b0060","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.vaccine.2016.03.084","article-title":"A prospective cohort study assessing the reactogenicity of pertussis and influenza vaccines administered during pregnancy","volume":"34","author":"Regan","year":"2016","journal-title":"Vaccine"},{"issue":"17","key":"10.1016\/j.vaccine.2018.07.011_b0065","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1001\/jama.2016.14432","article-title":"Tdap vaccination during pregnancy and microcephaly and other structural birth defects in offspring","volume":"316","author":"DeSilva","year":"2016","journal-title":"Jama"},{"issue":"7","key":"10.1016\/j.vaccine.2018.07.011_b0070","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.vaccine.2015.12.046","article-title":"Maternal Tdap vaccination: Coverage and acute safety outcomes in the vaccine safety datalink, 2007\u20132013","volume":"34","author":"Kharbanda","year":"2016","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2018.07.011_b0075","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1097\/AOG.0000000000000862","article-title":"Pregnancy outcomes after antepartum tetanus, diphtheria, and acellular pertussis vaccination","volume":"125","author":"Morgan","year":"2015","journal-title":"Obstetrics Gynecol"},{"issue":"8","key":"10.1016\/j.vaccine.2018.07.011_b0080","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1080\/21645515.2016.1157241","article-title":"Maternal and infant outcomes among women vaccinated against pertussis during pregnancy","volume":"12","author":"Berenson","year":"2016","journal-title":"Human Vacc Immunotherapeut"},{"key":"10.1016\/j.vaccine.2018.07.011_b0085","doi-asserted-by":"crossref","first-page":"g4219","DOI":"10.1136\/bmj.g4219","article-title":"Safety of pertussis vaccination in pregnant women in UK: observational study","volume":"349","author":"Donegan","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2018.07.011_b0090","unstructured":"The Institute of Environmental Science and Research Ltd. Notifiable and Other Diseases in New Zealand: Annual Report 2012. Porirua, New Zealand; 2013."},{"issue":"1","key":"10.1016\/j.vaccine.2018.07.011_b0095","doi-asserted-by":"crossref","first-page":"e009536","DOI":"10.1136\/bmjopen-2015-009536","article-title":"Infant outcomes after exposure to Tdap vaccine in pregnancy: an observational study","volume":"6","author":"Walls","year":"2016","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.vaccine.2018.07.011_b0100","doi-asserted-by":"crossref","first-page":"e010911","DOI":"10.1136\/bmjopen-2015-010911","article-title":"Safety of Tdap vaccine in pregnant women: an observational study","volume":"6","author":"Petousis-Harris","year":"2016","journal-title":"BMJ Open"},{"issue":"47","key":"10.1016\/j.vaccine.2018.07.011_b0105","doi-asserted-by":"crossref","first-page":"6441","DOI":"10.1016\/j.vaccine.2015.07.112","article-title":"Key terms for the assessment of the safety of vaccines in pregnancy: results of a global consultative process to initiate harmonization of adverse event definitions","volume":"33","author":"Munoz","year":"2015","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2018.07.011_b0110","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1467-842X.1998.tb01505.x","article-title":"NZDep91: A New Zealand index of deprivation","volume":"22","author":"Salmond","year":"1998","journal-title":"Australian New Zealand J Public Health"},{"issue":"20","key":"10.1016\/j.vaccine.2018.07.011_b0115","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1016\/j.vaccine.2016.03.049","article-title":"Enhanced surveillance of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccines in pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 2011\u20132015","volume":"34","author":"Moro","year":"2016","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2018.07.011_b0120","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1089\/jwh.2013.4506","article-title":"Prevalence and risk factors for early, undesired weaning attributed to lactation dysfunction","volume":"23","author":"Stuebe","year":"2014","journal-title":"J Women's Health"},{"issue":"27","key":"10.1016\/j.vaccine.2018.07.011_b0125","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1016\/j.vaccine.2015.04.097","article-title":"Chorioamnionitis following vaccination in the Vaccine Adverse Event Reporting System","volume":"33","author":"Datwani","year":"2015","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2018.07.011_b0130","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1086\/605575","article-title":"Seroprevalence of Bordetella pertussis infection during pregnancy measured by IgG antibodies against pertussis toxin","volume":"49","author":"Nooitgedagt","year":"2009","journal-title":"Clinical Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18309411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18309411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:27:39Z","timestamp":1759400859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18309411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":26,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0264410X18309411"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.07.011","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pertussis Immunisation in Pregnancy Safety (PIPS) Study: A retrospective cohort study of safety outcomes in pregnant women vaccinated with Tdap vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}